. 2020 Feb 24;15(2):e0229260. doi: 10.1371/journal.pone.0229260

Table 5. Correlation of antibody index of Goldmann-Witmer coefficient and glaucoma parameters.

		RV		CMV		HSV		VZV		MV
		AI	p	AI	p	AI	p	AI	p	AI	p
IOP before AC stab incision	IOP≤21 mmHg	21.6±41.18 (N = 56)	0.180	28.4±42.3 (N = 18)	0.943	9.07±13.7 (N = 60)	0.793	7.16±9.9 (N = 30)	0.373	4.3±1.7 (N = 10)	0.22
IOP before AC stab incision	IOP≥22 mmHg	45.7±73.8 (N = 20)	0.180	27.1±74.6 (N = 38)	0.943	10.2±13.06 (von N = 13)	0.793	13.6±26.4 (von N = 15)	0.373	2.98±2.7 (N = 3)	0.22
IOP before AC stab incision	IOP≤30 mmHg	21.3±42.9 (von N = 70)	0.066	22.7±35.3 (N = 32)	0.697	9.4±13.7 (N = 71)	0.476	9.7±18.7 (N = 37)	0.738	4.3±1.7 (N = 10)	0.57
IOP before AC stab incision	IOP≥31 mmHg	104.8±89.3 (N = 6)	0.066	33.99±92.3 (N = 24)	0.697	4.56±2.6 (von N = 2)	0.476	7.4±7.6 (von N = 8)	0.738	5.98±2.7 (N = 3)	0.57
Topical glaucoma therapy	no	32.2±57.4 (N = 45)	0.293	31.1±51.4 (N = 10)	0.889	8.3±7.06 (N = 35)	0.881	11.6±21.6 (N = 27)	0.175	3.6±1.1 (N = 5)	0.28
Topical glaucoma therapy	yes	21.7±44.0 (N = 31)	0.293	26.7±68.7 (N = 46)	0.889	10.16±17.5 (von N = 38)	0.881	5.79±5.32 (von N = 18)	0.175	5.36±2.2 (N = 8)	0.28
Systemic glaucoma therapy (acetazolamid)	no	26.2±49.9 (N = 70)	0.665	34.4±82.9 (N = 34)	0.211	9.58±13.9 (N = 68)	0.437	8.5±17.6 (N = 35)	0.563	3.82±0.89 (N = 9)	0.14
Systemic glaucoma therapy (acetazolamid)	yes	47.8±78.7 (N = 6)	0.665	16.8±16.02 (N = 22)	0.211	4.97±2.02 (von N = 5)	0.437	11.99±16.4 (N = 10)	0.563	6.64±2.59 (N = 4)	0.14
Glaucoma surgery	no	28.54±53.6 (N = 65)	0.319	29.6±69.0 (N = 50)	0.268	9.56±13.9 (N = 68)	0.679	9.59±17.6 (von N = 43)	0.068	4.51±1.78 (N = 11)	0.98
Glaucoma surgery	yes	24.3±45.7 (N = 11)	0.319	9.8±10.99 (N = 6)	0.268	5.23±2.32 (N = 5)	0.679	3.15±0.13 (N = 3)	0.068	5.68±3.8 (N = 2)	0.98

AC = anterior chamber, AI = antibody index, CMV = cytomegalovirus, HSV = herpes simplex virus, IOP = intraocular pressure, VZV = varicella-zoster virus